成分分析

UPLC-MS/MS 法测定胜红蓟中6 个吡咯里西啶 生物碱的含量及风险评估*

展开
  • 中国食品药品检定研究院,北京 100050
第一作者:Tel:(010)67095424;E-mail:6206310@qq.com
** 马双成 Tel:(010)67095272;E-mail:masc@nifdc.org.cn ;刘丽娜 Tel:(010)67095424;E-mail:kllln@163.com

收稿日期: 2020-06-19

  网络出版日期: 2024-07-11

基金资助

*科技部重大新药创制( 项目编号:2018ZX09303-024,2018ZX09735-006)

Risk assessment and determination of six main pyrrolizidine alkaloids in Agerati Conyzoidis Herba by UPLC-MS/MS*

Expand
  • National Institutes for Food and Drug Control,Beijing 100050,China

Received date: 2020-06-19

  Online published: 2024-07-11

摘要

目的: 建立UPLC-MS/MS 法测定胜红蓟中6 个吡咯里西啶生物碱(石胺松、凌德草碱、刺凌德草碱、N-氧化凌德草碱、N-氧化刺凌德草碱和N-氧化石胺松)的含量,并根据测定结果进行初步的风险评估。方法: 采用ACQUITY UPLC HSS T3 色谱柱(100 mm×2.1 mm,1.8 μm),以含0.05% 甲酸和2.5 mmol·L-1 甲酸铵的水溶液(A)及含0.05% 甲酸和2.5 mmol·L-1 甲酸铵的乙腈溶液(B)为流动相,梯度洗脱,流速为0.3 mL·min-1,柱温为40 ℃ ;电喷雾离子源,正离子多反应模式监测,外标法测定。结果: 石胺松、凌德草碱、刺凌德草碱、N-氧化凌德草碱、N-氧化刺凌德草碱和N-氧化石胺松质量浓度分别在0.972~97.2、0.964~96.4、1.016~101.6、1.056~105.6、1.032~103.2 和0.958~95.8 ng·mL-1 范围内与峰面积呈现良好的线性关系(r>0.999 0);平均加样回收率分别为88.5%、90.2%、92.6%、94.3%、91.8% 和95.7%,RSD 分别为3.1%、3.5%、2.4%、2.1%、2.5% 和3.2%。6 批胜红蓟样品中石胺松、凌德草碱、刺凌德草碱、N-氧化凌德草碱、N-氧化刺凌德草碱和N-氧化石胺松的含量范围分别为1.22~2.87、0.36~0.75、4.23~10.65、1.08~3.65、10.31~24.26 和5.25~13.36 μg·g-1结论: 本研究所建立的方法可同时测定胜红蓟中6 个主要吡咯里西啶生物碱含量。初步风险评估显示,该药材存在一定的用药安全风险。

本文引用格式

昝珂, 李耀磊, 王莹, 王赵, 金红宇, 刘丽娜, 马双成 . UPLC-MS/MS 法测定胜红蓟中6 个吡咯里西啶 生物碱的含量及风险评估*[J]. 药物分析杂志, 2021 , 41(7) : 1169 -1175 . DOI: 10.16155/j.0254-1793.2021.07.08

Abstract

Objective: To establish a method for the simultaneous determination of six main pyrrolizidine alkaloids (lycopsamine,rinderine,echinatine,rinderine N-oxide,echinatine N -oxide,and lycopsamine N -oxide) in Agerati Conyzoidis Herba by UPLC-MS/MS. And to carry out preliminary risk assessment according to the research results. Methods: The assay was performed on a ACQUITY UPLC HSS T3 column( 2.1 mm×100 mm,1.8 μm) and the sample was eluted with a gradient mobile phase consisting of 0.05% formic acid and 2.5 mmol·L-1 ammonium formate in water(A)-0.05% formic acid and 2.5 mmol·L-1 ammonium formate in acetonitrile(B),the flow rate was 0.3 mL·min-1,the column temperature was 40 ℃. The MS system was operated by using electrospray ionization(ESI) in the positive ion mode,and the scan mode was in multiple reactions monitoring(MRM) mode. External standard method was used in the experiment. Results: The linear ranges of lycopsamine,rinderine,echinatine,rinderine N-oxide,echinatine N -oxide,and lycopsamine N -oxide were 0.972-97.2,0.964-96.4,1.016-101.6,1.056-105.6,1.032-103.2 and 0.958-95.8 ng·mL-1,respectively(r> 0.999 0). The average recoveries were 88.5%,90.2%,92.6%,94.3%,91.8% and 95.7% with RSD of 3.1%,3.5%, 2.4%,2.1%,2.5% and 3.2%,respectively. The content ranges of lycopsamine,rinderine,echinatine,rinderine N-oxide,echinatine N-oxide,and lycopsamine N-oxide in the 6 batches of Agerati Conyzoidis Herba were 1.22- 2.87,0.36-0.75,4.23-10.65,1.08-3.65,10.31-24.26 and 5.25-13.36 μg·g-1,respectively. Conclusion: The established method can simultaneously determine six pyrrolizidine alkaloids in Agerati Conyzoidis Herba. The preliminary risk assessment showes that there is a certain risk of drug safety.

参考文献

[1] 唐秀能,韦红棉.藿香蓟药理作用及其临床应用研究进展[J]. 广西中医药大学学报,2014,17(2):114
TANG XN,WEI HM.Research progress in pharmacological action and clinical application of Agerati Conyzoidis Herba[J].J Guangxi Univ Chin Med,2014,17(2):114
[2] 黄再强,胡明勋,张燕飞,等.民族药胜红蓟的药用研究进展[J].中药与临床,2016,7(4):42
HUANG ZQ,HU MX,ZHANG YF,et al.Medicinal research progress of ethnic drug Shenghongji[J].Pharm Clin Chin Mater Med,2016,7(4):42
[3] 中国植物志编辑委员会.中国植物志.第74 卷[M].北京:科学出版社,1985:53
Editorial Committee of Flora of China.Flora of China.Vol. 74[M]. Beijing:Science Press,1985:53
[4] YADAV N,GANIE SA,SINGH B,et al.Phytochemical constituents and ethnopharmacological properties of Ageratum conyzoides L.[J]. Phytother Res,2019,33(9):2163
[5] VYAS AV,MULCHANDANI NB.Polyoxygenated flavones from Ageratum conyzoides[J].Phytochemistry,1986,25(11):2625
[6] TAN DP,YAN QX.Chemical constituents of the aerial parts of Ageratum conyzoides[J].Chem Nat Compd,2019,55(6):1145
[7] GONZALEZ AG,AGUIAR ZE,GRILLO TA,et al.Methoxyflavones from Ageratum conyzoides[J].Phytochemistry,1991,30(4):1269
[8] GONZALEZ AG,AGUIAR ZE,GRILLO TA,et al.Chromenes from
Ageratum conyzoides[J].Phytochemistry,1991,30(4):1137
[9] ADEBAYO AH,JI CJ,ZHANG YM,et al.A new chromene isolated from Ageratum conyzoides[J].Nat Prod Commun,2011,6(9): 1263
[10] DESTA T,AFEWORK M,UNNITHAN CR,et al.Isolation and structural elucidation of toxic pyrrolizidine alkaloids from Ageratum conyzoides collected from VOD disease affected communities[J]. Int J Pharm Technol,2014,6(1):6281
[11] WIEDENFELD H,RODER E.Pyrrolizidine alkaloids from Ageratum conyzoides[J].Planta Med,1991,57(6):578
[12] BOSI CF,ROSA DW,GROUGNET R,et al.Pyrrolizidine alkaloids in medicinal tea of Ageratum conyzoides[J].Rev Bras Farmacogn, 2013,23(3):425
[13] AVULA B,SAGI S,WANG YH,et al.Characterization and screening of pyrrolizidine alkaloids and N-oxides from botanicals and dietary supplements using UHPLC-high resolution mass spectrometry[J].Food Chem,2015,178:136
[14] FAQUETI LG,SANDJO LP,BIAVATTI MW.Simultaneous identification and quantification of polymethoxyflavones,coumarin and phenolic acids in Ageratum conyzoides by UPLC-ESI-QToF-MS and UPLC-PDA[J].J Pharm Biomed Anal,2017,145:621
[15] 高江国,王长虹,李岩,等.吡咯里西啶生物碱的药理作用、毒性及药(毒)物代谢动力学研究进展[J].中国中药杂志,2009,34(5):506
GAO JG,WANG CH,LI Y,et al.Advance on pharmacologic actions,toxicity and pharmacokinetics of pyrrozidine alkaloids[J]. China J Chin Mater Med,2009,34(5):506
[16] STEINHOFF B.Pyrrolizidine alkaloid contamination in herbal medicinal products:limits and occurrence[J].Food Chem Toxicol, 2019,130:262
[17] SCHRENK D,GAO L,LIN G,et al.Pyrrolizidine alkaloids in food and phytomedicine:occurrence,exposure,toxicity,mechanisms, and risk assessment—A review[J].Food Chem Toxicol,2020, 136:1
[18] 湖南省中药材标准[S].2009:254
Hunan Standard for Chinese Materia Medica[S].2009:254
[19] World Health Organization.Pyrrolizidine Alkaloids Health and Safety Guide[S].1989:26
[20] European Medicines Agency.Public Statement on Contamination of Herbal Medicinal Products/Traditional Herbal Medicinal Products with Pyrrolizidine Alkaloids[R/OL].[2016-5-31]. http://www.ema.europa.eu/docs/en_gb/document_library/public_ statement/2016/06/wc500208195.pdf
文章导航

/